Skip to main content
Supplement Research and Comparison WebsiteBest Price Guarantee
Supplement Research and Comparison Website

Abstract

In present study, we investigated the probiotic potential of three Pediococcus spp. isolated from Iranian traditional fermented cereal-dairy product, Tarkhineh. These 3 strains were identified as Pediococcus acidilactici VKU2, P. acidilactici IAH-5 and P. pentosaceus DHR005 by 16S rRNA gene sequencing. All the strain were found tolerate to pH 3 and 0.3% oxall for 3 h as well as simulated gastric and intestinal juice. P. acidilactici IAH-5 showed the highest cholesterol removal (67.52%), hydroxyl radical scavenging activity (58.32%), hydrophobicity (40.3%) and auto-aggregation (48%). Pediococcus spp. inhibited the growth of tested pathogens (Escherichia coli ATCC 25922, Pseudomonas aeruginosa PTCC 1707, Salmonella typhimurium PTCC 1609, and Staphylococcus aureus ATCC 25923) which the most susceptible strain was S. aureus. In competition assay, P. acidilactici IAH-5 was able to inhibited adhesion of 67.3% of S. typhimurium and in inhibition assay 45.8% of the pathogenic adhesion to Caco-2 cells were decreased. P. acidilactici VKU2 and P. acidilactici IAH-5 showed 16.32 and 12.25% adhesion to simulated epithelial cell line which were also confirmed by scanning electron microscopy. Pediococcus spp. did not showed DNase production or hemolytic activity which confirm its safety aspects. Our findings suggested that the P. acidilactici IAH-5 has the best properties with probiotic features and cholesterol assimilation for its application as novel bio-therapeutic and bio-preservation agents.

Keywords: Antagonistic activity; Caco-2 cell line; Pediococcus; Probiotics; Serum cholesterol.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Pediococcus acidilacticiImproved Cholesterol LevelsBeneficial
Large
Pediococcus acidilacticiIncreased Antioxidant ActivityBeneficial
Moderate
Pediococcus acidilacticiReduced Pathogenic Adhesion to Intestinal CellsBeneficial
Moderate
Pediococcus acidilacticiReduced Pathogenic Bacterial GrowthBeneficial
Large
Pediococcus acidilactici KABP™-021Improved Gastric ToleranceBeneficial
Moderate
Pediococcus acidilactici KABP™-021Improved Oxalic Acid ToleranceBeneficial
Moderate
Pediococcus acidilactici KABP™-021Increased Antioxidant ActivityBeneficial
Moderate
Pediococcus acidilactici KABP™-021Increased Cell AdhesionBeneficial
Moderate
Pediococcus acidilactici KABP™-021Reduced Pathogen Adhesion to CellsBeneficial
Moderate
Pediococcus acidilactici KABP™-021Reduced Pathogen GrowthBeneficial
Large
Pediococcus acidilactici KABP™-021Reduced Total Cholesterol LevelsBeneficial
Large
Back to top